TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

XYREM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

XYREM

ST13

US500000078769796

Class

5

Filing

78769796

Registration

3309255

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

46

Latest update

11/30/2025

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

12/08/2005

Registration date

10/09/2007

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/25/2017

Last transaction

11/30/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/24/1999

First use in commerce

02/24/1999

Drawing code

4

Owner type

03

Owner location

Palo Alto, CA

Examiner

PEETE,KYLE C

Law office

M30

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

JAZZ PHARMACEUTICALS, INC.
JPI COMMERCIAL, LLC
Orphan Medical, Inc.

Representatives

Michael Olsen Winthrop & Weinstine, P.A.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

[Pain relief medication; preparation for the relief of pain;] pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for use in the treatment and/or management of sleep disorders, [ chronic fatigue syndrome, drug and alcohol abuse, anxiety, cerebrovascular diseases,] neurological disorders,[ parkinson's disease, alzheimer's disease, multiple sclerosis, autism, depression, inflammatory disorders, irritable bowel disorder, regional ileitis, ulcerative colitis, automimmune inflamatory disorders, endocrine disturbances, and diabetes; and pharmaceutical preparations for the purpose of tissue protection including protection following hypoxia/anoxia such as in stroke, organ transplantation, organ preservation, myocardial infarction or ischemia, reperfusion injury, and protection following radiation, progeria, or an increased level of intracranial pressure, e.g., due to head trauma. ]

Publications

History of USPTO decisions and trademark events.

46 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/11/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/11/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/11/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/11/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/11/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/26/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/15/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/15/2019

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/23/2018

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/23/2018

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/25/2017

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

10/25/2017

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/25/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/24/2017

E89R

TEAS SECTION 8 & 9 RECEIVED

09/27/2017

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

10/09/2016

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

07/27/2016

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

03/09/2016

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

07/22/2015

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

11/16/2013

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/16/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/16/2013

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

10/31/2013

E815

TEAS SECTION 8 & 15 RECEIVED

10/31/2013

A7OK

AMENDMENT UNDER SECTION 7 - PROCESSED

07/07/2012

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/07/2012

AMD7

SEC 7 REQUEST FILED

06/29/2012

MAIL

PAPER RECEIVED

06/29/2012

CCON

COUNTERCLAIM OPP. NO. 999999

10/23/2009

CCON

COUNTERCLAIM OPP. NO. 999999

07/29/2009

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

12/24/2008

R.PR

REGISTERED-PRINCIPAL REGISTER

10/09/2007

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

08/31/2007

ALIE

ASSIGNED TO LIE

08/31/2007

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

07/23/2007

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/30/2007

IUAF

USE AMENDMENT FILED

03/30/2007

EISU

TEAS STATEMENT OF USE RECEIVED

03/30/2007

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

10/31/2006

PUBO

PUBLISHED FOR OPPOSITION

08/08/2006

NPUB

NOTICE OF PUBLICATION

07/19/2006

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

06/20/2006

ALIE

ASSIGNED TO LIE

06/16/2006

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/10/2006

DOCK

ASSIGNED TO EXAMINER

06/08/2006

NWAP

NEW APPLICATION ENTERED

12/13/2005

Continuous trademark protection

Get notified about every new filing that threatens XYREM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.